· Hilt, R. J., & Nussbaum, A. M. (2016).  . American Psychiatric Association Publishing.

· Chapter 14, “Psychosocial Interventions”

· Chapter 15, “Psychotherapeutic Interventions”

· Chapter 16, “Psychopharmacological Interventions”Links to an external site.

· Thapar, A., Pine, D. S., Leckman, J. F., Scott, S., Snowling, M. J., & Taylor, E. A. (2015).  Rutter’s child and adolescent psychiatry (6th ed.). Wiley Blackwell.

· Chapter 43, “Pharmacological, Medically-Led and Related Treatments”

· Walden University. (n.d.).  . https://academicguides.waldenu.edu/ld.php?content_id=51901492Links to an external site.

· Zakhari, R. (2020).  The psychiatric-mental health nurse practitioner certification review manual. Springer.

· Chapter 5, “Psychopharmacology”


· CriticalThinkRx. (2019, June 9).   [Video]. YouTube. https://youtu.be/Gbq6RnOsGKQLinks to an external site.

· CriticalThinkRx. (2019, June 9).   [Video]. YouTube. https://youtu.be/NRef-g4Ding


Winters, D. E., Fukui, S., Leibenluft, E., & Hulvershorn, L. A. (2018). Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.  Journal of Child & Adolescent Psychopharmacology28(5), 298–305.

Tapia, V., & John, R. M. (2018). Disruptive Mood Dysregulation Disorder.  Journal for Nurse Practitioners14(8), 573–578.

Pan, P.-Y., Fu, A.-T., & Yeh, C.-B. (2018). Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.  Journal of Child & Adolescent Psychopharmacology28(10), 682–689.

Rice, T., Simon, H., Barckak, D., Maiyuran, H., Chan, V., Hassan, Y., Tatum, J., & Coffey, B. J. (2019). Amantadine for Treatment of Disruptive Mood Dysregulation Disorder Symptoms.  Journal of Child & Adolescent Psychopharmacology29(8), 642–646.

Le, J., Feygin, Y., Creel, L., Lohr, W. D., Jones, V. F., Williams, P. G., Myers, J. A., Pasquenza, N., & Davis, D. W. (2020). Trends in diagnosis of bipolar and disruptive mood dysregulation disorders in children and youth.  Journal of Affective Disorders264, 242–248.

Uran, P., & Kılıç, B. G. (2020). Family Functioning, Comorbidities, and Behavioral Profiles of Children With ADHD and Disruptive Mood Dysregulation Disorder.  Journal of Attention Disorders24(9), 1285–1294.

Linke, J., Kircanski, K., Brooks, J., Perhamus, G., Gold, A. L., & Brotman, M. A. (2020). Exposure-Based Cognitive-Behavioral Therapy for Disruptive Mood Dysregulation Disorder: An Evidence-Based Case Study.  Behavior Therapy51(2), 320–333.

Mulraney, M., Schilpzand, E., Hazell, P., Nicholson, J., Anderson, V., Efron, D., Silk, T., & Sciberras, E. (2016). Comorbidity and correlates of disruptive mood dysregulation disorder in 6-8-year-old children with ADHD.  European Child & Adolescent Psychiatry25(3), 321–330.

Lin, Y.-J., Tseng, W.-L., & Gau, S. S.-F. (2021). Psychiatric comorbidity and social adjustment difficulties in children with disruptive mood dysregulation disorder: A national epidemiological study.  Journal of Affective Disorders281, 485–492.